Overview of coagulation factors and platelet counts in patients with type 2 diabetes mellitus: a cross-sectional study
DOI:
https://doi.org/10.30989/mik.v14i2.1314Keywords:
Blood coagulation tests, clotting factors, diabetes complications, hematologic diseases, platelet function tests, type 2 diabetes mellitusAbstract
Background: Type 2 diabetes mellitus (T2DM) is a growing global health threat, where chronic hyperglycemia and insulin resistance can affect coagulation profiles.
Objective: This study aims to examine coagulation factor profiles and platelet counts in T2DM patients.
Methods: A descriptive cross-sectional observational study using data from prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), and platelet counts of T2DM patients admitted to the Internal Medicine Ward of Dr. M. Djamil General Hospital, Padang, in October 2023. Data analysis was performed descriptively using SPSS v26 software.
Results: Of the 39 patients analyzed, the distribution of characteristics showed a male predominance of 64.1%, with the largest age group being 45–59 years (48.7%). The most common complication associated with T2DM was chronic kidney disease, identified in 82.1% of the study population. Evaluation of hemostasis parameters showed that APTT was prolonged in 56.4% of patients. Conversely, PT (87.2%), INR (87.2%), and platelet count (66.7%) were within reference ranges.
Conclusion: This study found most coagulation parameters normal, but a relatively high proportion had prolonged APTT, underscoring the need for individualized coagulation monitoring in T2DM, especially with renal complications
References
1. World Health Organization. Diabetes. April 5, 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
2. Badan Penelitian Dan Pengembangan Kesehatan. Hasil Utama Riskesdas 2018. Lembaga Penerbit Badan Penelitian Dan Pengembangan Kesehatan; 2018.
3. Fan W. Epidemiology In Diabetes Mellitus And Cardiovascular Disease. Cardiovasc Endocrinol. 2017;6(1):8-16.
4. Mukhyarjon, Wahid I, Manaf A. Profil Dan Beberapa Faktor Yang Berhubungan Dengan Hemostasis Pasien Diabetes Melitus Tipe 2 Tak Terkontrol. Jurnal Kedokteran Dan Kesehatan. 2020;16.
5. Suharti C. Dasar-Dasar Hemostasis. In: 2009.
6. Setiabudy Rd. Hemostasis Dan Trombosis. 6th Ed. Badan Penerbit Fakultas Kedokteran Universitas Indonesia; 2018.
7. Durachim A, Astuti D. Buku Ajar Teknologi Laboratorium Medik Hemostasis. Pertama.; 2018.
8. Ardina R, Sartika F, Nainggolan Lp. APTT (Activated Partial Thromboplastin Time) and PT (Prothrombin Time) Pada Penderita Diabetes Melitus Tipe 2 di RSUD Dr. Doris Sylvanus Palangkaraya. Borneo Journal of Medical Laboratory Technology APTT. 2020;2(2).
9. Herawati F, Umar F, Pahlemy H, et al. Pedoman Interpretasi Data Klinik.; 2011.
10. Pramudita N, Mulyantari NK. Gambaran Hasil Pemeriksaan Faal Hemostasis Pada Penderita Diabetes Melitus Tipe-2 (DM-2) Di RSUP Sanglah, Bali, Indonesia. Intisari Sains Medis. 2019;10(2).
11. Nordström A, Hadrévi J, Olsson T, Franks PW, Nordström P. Higher Prevalence of Type 2 Diabetes in Men than in Women is Associated with Differences in Visceral Fat Mass. Journal of Clinical Endocrinology and Metabolism. 2016;101(10):3740-3746.
12. Aryndra R, Kabosu S, Adu Aa, Et Al. Faktor Risiko Kejadian Diabetes Melitus Tipe Dua di RS Bhayangkara Kota Kupang. Vol 1.; 2019.
13. Nowakowska M, Zghebi SS, Ashcroft DM, et al. The Comorbidity Burden of Type 2 Diabetes Mellitus: Patterns, Clusters and Predictions from a Large English Primary Care Cohort. BMC Med. 2019;17(1):145.
14. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining Comorbidity: Implications for Understanding Health and Health Services. The Annals of Family Medicine. 2009;7(4):357-363.
15. Thukral S, Hussain S, Bhat S, Kaur N, Reddy A. Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) in Type 2 Diabetes Mellitus, a Case Control Study. International Journal of Contemporary Medical Research [IJCMR]. 2018;5(8).
16. Ebrahim H, Asrie F, Getaneh Z. Basic Coagulation Profiles and Platelet Parameters among Adult Type 1 and Type 2 Diabetes Patients at Dessie Referral Hospital, Northeast Ethiopia: Comparative Cross-Sectional Study. J Blood Med. 2021; Volume 12:33-42.
17. Li X, Weber NC, Cohn DM, et al. Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis. J Clin Med. 2021;10(11).
18. Perdamaian G, Tobing Ml. Gambaran Koagulasi pada Darah Pasien Diabetes Melitus yang Menjalani Hemodialisis (di RSUP Dr.Kariadi Semarang). Vol 4.; 2015.
19. Ephraim RKD, Awuku YA, Adu P, et al. High Risk of Coagulopathy among Type-2 Diabetes Mellitus Clients at a Municipal Hospital in Ghana. Ghana Med J. 2017;51(3):101.
20. B A, Sodhi HS, Modala S, Baghel M. A Comparative Study of Coagulation Time in Type 2 Diabetes Mellitus and Healthy Individuals. Vol 3.; 2016.
21. Hasanah AD. Gambaran Jumlah Trombosit Pada Penderita Diabetes Melitus Tipe 2 di RSU Bunda Palembang Tahun 2019. Published Online 2019.
22. Raja V, Ganapathy S, Karthikean SK, Das Prakash P. Impact of Haemodialysis on Coagulation Profile in Chronic Kidney Disease. Annals of Pathology and Laboratory Medicine. 2021;8(3):A95-99.
23. Budiman A, Yuliandari A, Sembiring RS. Gambaran Jumlah Trombosit Pada Pasien Diabetes Melitus Tipe 2. Zahra: Journal of Health and Medical Research. 2022;2(4):276-283.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 MEDIA ILMU KESEHATAN

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Articles received and published by the Media Ilmu Kesehatan are by the publication, the copyright of the article is fully transferred to the Media Ilmu Kesehatan. All operational forms such as printing, publication, and distribution of hard file journals are carried out by the Media Ilmu Kesehatan. Articles that have finished the review process and have been declared accepted by the journal manager or editor will be asked to fill out a statement of submission of copyright by the journal secretary to the main author or correspondent author. The statement of transfer of copyright is signed with a seal and sent via email to journalmik2018@gmail.com and contacted the admin of the journal to be followed up on archiving. Journal managers and editors have the right to edit the manuscript according to the provisions of the writing rules in the Media Ilmu Kesehatan.
Articles that have been declared accepted either online through the author's account on the OJS website https://ejournal.unjaya.ac.id/index.php/mik or a letter of receipt of the article (LOA), as well as those that have been published on OJS are not allowed to be published in other journals, or proceedings. The number of authors with more than one and as the main author or designated as the correspondent writer must have coordinated with members of the research team. The order of the authors submitted in the article as the author of one, two, three and so on cannot be changed when the article is published unless an error occurs in the technical operation of the journal.